Wei Wen-Cheng, Hsin Chun-Hsien, Yang Hsuan-Tzu, Su Ta-Wei, Su I-Hao, Chu Sung-Yu, Ko Po-Jen, Yu Sheng-Yueh, Lee Chun-Hui
Department of Cardiovascular Surgery, Kang-Ning General Hospital, Taipei, Taiwan.
Division of Thoracic & Cardiovascular Surgery, Chang Gung Memorial Hospital Linkou Main Branch and Chang Gung University, Taoyuan, Taiwan.
J Int Med Res. 2022 Jun;50(6):3000605221100134. doi: 10.1177/03000605221100134.
May-Thurner syndrome (MTS) is an anatomic stenotic variation associated with deep vein thrombosis (DVT) of the left leg. The classical DVT treatment strategy is medical treatment without thrombus removal. This study was performed to assess the clinical outcomes of the combination of AngioJet™ rheolytic thrombectomy and stenting for treatment of MTS-related DVT.
We conducted a retrospective cohort study of patients treated for MTS-related DVT from January 2017 to June 2020 at a single institution.
Fourteen patients (nine women) underwent AngioJet™ rheolytic thrombectomy for MTS-related DVT during the study period. The median DVT onset time was 8 days (interquartile range (IQR), 3-21 days). The median procedure time was 130 minutes (IQR, 91-189 minutes), and the median hospital stay was 7 days (IQR, 5-26 days). One patient had a residual thrombus and occluded iliac stent and underwent adjuvant catheter-directed thrombolysis for revascularization. The primary patency rate for the iliac stent was 92.9% at 12 months.
Concomitant AngioJet™ rheolytic thrombectomy and stenting of MTS-induced lesions may be beneficial for patients with MTS-related DVT.
梅-图二氏综合征（MTS）是一种与左腿深静脉血栓形成（DVT）相关的解剖性狭窄变异。经典的DVT治疗策略是药物治疗，不进行血栓清除。本研究旨在评估AngioJet™ 血栓消融术联合支架置入术治疗MTS相关DVT的临床疗效。
我们对2017年1月至2020年6月在单一机构接受MTS相关DVT治疗的患者进行了一项回顾性队列研究。
在研究期间，14例患者（9例女性）接受了AngioJet™ 血栓消融术治疗MTS相关DVT。DVT的中位发病时间为8天（四分位间距（IQR），3 - 21天）。中位手术时间为130分钟（IQR，91 - 189分钟），中位住院时间为7天（IQR，5 - 26天）。1例患者有残余血栓和髂静脉支架闭塞，接受了辅助导管直接溶栓以实现血管再通。髂静脉支架在12个月时的原发性通畅率为92.9%。
AngioJet™ 血栓消融术联合MTS病变部位支架置入术可能对MTS相关DVT患者有益。
